Treatment of asthma during pregnancy: More solid evidence needed

Thorax

Volumn 63, Issue 11, 2008, Pages 944-945

  Cazzola, Mario ^a   Matera, Maria Gabriella ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; THEOPHYLLINE;

ASTHMA; CLEFT FACE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG SAFETY; EDITORIAL; GASTROSCHISIS; HUMAN; LIMB REDUCTION DEFECT; NEURAL TUBE DEFECT; PREGNANCY; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; TERATOGENICITY;

EID: 56149106066     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.104463     Document Type: Editorial

References (19)

1. Tata LJ, Lewis SA, McKeever TM, et al. Effect of matemal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study. Thorax 2008;63:981-7.
2. Chambers K. Asthma education and outcomes for women of childbearing age. Case Manager 2003;14:58-61.
3. Enriquez R, Wu P, Griffin MR, et al. Cessation of asthma medication in early pregnancy. Am J Obstet Gynecol 2006;195:149- 53.
4. Wendel PJ, Ramin SM, Barnett-Hamm C, et al. Asthma treatment in pregnancy: a randomized controlled study. Am J Obstet Gynecol 1996;175:150-4.
5. Cydulka RK, Emerman CL, Schreiber D, et al. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med 1999;160:887-92.
6. Enriquez R, Griffin MR, Carroll KN, et al. Effect of maternal asthma and asthma control on pregnancy and perinatal outcomes. J Allergy Clin Immunol 2007;120:625-30.
7. National Asthma Education Program Report of the Working Groups on Asthma and Pregnancy Management of asthma during pregnancy. NIH Publication No 93-3279A. Bethesda, MD: National Institutes of Health, 1993.
8. Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 2006;61:169-76.
9. NAEPP Expert Panel Report 3 (EPR-3). Guidelines for the diagnosis and management of asthma: summary report 2007. J Allergy Clin Immunol 2007;120:S94-138.
10. Blais L, Beauchesne M-F, Rey É, et al. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma. Thorax 2007;62:320-8.
11. Schatz M, Dombrowski MP, Wise R, et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol 2004;113:1040-5.
12. Hanania NA, Cazzola M. Acute respiratory failure during pregnancy. Eur Respir Mon 2006;36:241-58.
13. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on asthma management: a national clinical guideline. Thorax 2003;58(Suppl 1):i47-58.
14. Liccardi G, Cazzola M, Canonica GW, et al. General strategy for the management of bronchial asthma in pregnancy. Respir Med 2003;97:778-89.
15. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999;86:242-4.
16. Lin S, Munsie JP, Herdt-Losavio ML, et al. Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol 2008;168:73-9.
17. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 2. Infant characteristics excluding congenital malformations. Eur J Clin Pharmacol 2007;63:375-81.
18. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants. Eur J Clin Pharmacol 2007;63:383-8.
19. Gluck JC, Gluck PA. Asthma controller therapy during pregnancy. Am J Obstet Gynecol 2005;192:369-80.